EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DEP-1 is a brain insulin receptor phosphatase that prevents the simultaneous activation of counteracting metabolic pathways

Simran Chopra, Otsuware Linda-Josephine Kadiri, Jannis Ulke, Robert Hauffe, Wenke Jonas, Sahar Cheshmeh, Luisa Schmidt, Christopher A Bishop, Selma Yagoub, Mareike Schell, Michaela Rath, Janine Krüger und 4 weitere

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114984 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Simran Chopra und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Experimental Nutritional Medicine, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-11…. Hauptthemen laut MEDLINE: Receptor, Insulin, Brain, Mice, Knockout. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Diabetes Gesellschaft, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A healthy metabolism relies on precise regulation of anabolic and catabolic pathways. While insulin deficiency impairs anabolism, insulin resistance in obesity causes metabolic dysfunction, especially via altered brain insulin receptor (IR) activity. Density-enhanced phosphatase 1 (DEP-1) negatively modulates the IR in peripheral tissues. Our study shows that DEP-1 is an insulin-regulated gene, dysregulated in obesity, and uncovers its role in brain insulin signaling, impacting both anabolic and catabolic pathways. Neuro-2a cells lacking DEP-1 demonstrated heightened IR phosphorylation upon acute insulin stimulation. This coincided with simultaneous AMP-activated protein kinase (AMPK) activation, which governs catabolic pathways, due to increased phospholipase C-gamma 1 signaling. These opposing pathways in male DEP-1 forebrain-specific knockout mice resulted in elevated lipolysis in white adipose tissue and fat oxidation in brown adipose tissue, with enhanced sympathetic activation and β-adrenergic receptor expression. In conclusion, DEP-1 deficiency causes the simultaneous activation of IR and AMPK signaling in the brain, with enhanced sympathetic activity in adipose tissues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, InsulinBrainMice, KnockoutAnimalsMiceMaleAMP-Activated Protein KinasesSignal TransductionMetabolic Networks and PathwaysInsulinAdipose Tissue, BrownLipolysisMice, Inbred C57BLPhosphorylationAdipose Tissue, WhiteObesity

Stichwörter der Autor:innen

AMPK ActivationCP: MetabolismCP: Neuroscienceanabolic and catabolic Pathwaysbeta adrenergic activitybrain insulin resistancedensity-enhanced phosphatase-1 (DEP-1)insulin receptorinsulin signalingobesitysympathetic activation

Substanzen

Receptor, InsulinAMP-Activated Protein KinasesInsulin

Autor:innen und Institutionen

  • Department of Molecular and Experimental Nutritional Medicine, Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.
  • Institute of Diagnostic Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Augustenburger P…
  • Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), 14558 Nuthetal, Germany; German Center for Diabetes Research (DZD), 85764 München-Neuherberg, Germany.
  • Institute for Genetics, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
  • Department Physiology of Energy Metabolism, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), 14558 Nuthetal, Germany.
  • Department of Neurocircuit, Development and Function, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), 14558 Nuthetal, Germany.

Förderung

  • Deutsche Diabetes Gesellschaft
  • German Research Foundation

Zitieren

APA

Chopra, S., Kadiri, O. L., Ulke, J., Hauffe, R., Jonas, W., Cheshmeh, S., Schmidt, L., Bishop, C. A., Yagoub, S., Schell, M., Rath, M., Krüger, J., Lippert, R. N., Krüger, M., Kappert, K., & Kleinridders, A. (2024). DEP-1 is a brain insulin receptor phosphatase that prevents the simultaneous activation of counteracting metabolic pathways. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114984

Vancouver

Chopra S, Kadiri OL, Ulke J, Hauffe R, Jonas W, Cheshmeh S, et al. DEP-1 is a brain insulin receptor phosphatase that prevents the simultaneous activation of counteracting metabolic pathways. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114984

BibTeX
@article{Chopra2024,
  author = {Chopra, Simran and Kadiri, Otsuware Linda-Josephine and Ulke, Jannis and Hauffe, Robert and Jonas, Wenke and Cheshmeh, Sahar and Schmidt, Luisa and Bishop, Christopher A and Yagoub, Selma and Schell, Mareike and Rath, Michaela and Krüger, Janine and Lippert, Rachel N and Krüger, Marcus and Kappert, Kai and Kleinridders, André},
  title = {DEP-1 is a brain insulin receptor phosphatase that prevents the simultaneous activation of counteracting metabolic pathways},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114984}
}
Kostenlos starten →